QID 43856

Date Published: 2021-10-05

QID 43856: Hewlett Packard Enterprise (HPE) ArubaOS SAD Domain Name System (DNS) Side Channel Vulnerability (ARUBA-PSA-2021-008)

Aruba Networks provides data networking solutions for enterprises and businesses worldwide.

CVE-2020-25705: A vulnerability made public under the name SAD DNS affects Domain Name System resolvers due to a vulnerability in the Linux kernel when handling ICMP packets. This vulnerability is present in some Aruba products which are listed below.
Affected Versions:
-- ArubaOS 6.4.x prior to 6.4.4.25
-- ArubaOS 6.5.x: prior to 6.5.4.19
-- ArubaOS 8.3.x: prior to 8.3.0.15
-- ArubaOS 8.5.x: prior to 8.5.0.12
-- ArubaOS 8.6.x: prior to 8.6.0.8
-- ArubaOS 8.7.x: prior to 8.7.1.2
-- ArubaOS prior to 2.2.0.4

QID Detection Logic (Unauthenticated):
This QID gets the vulnerable ArubaOS version via SNMP.

A flaw in the way reply ICMP packets are limited in the Linux kernel was found that allows for quick scanning of open UDP ports. This flaw allows an off-path remote user to effectively bypass source port UDP randomization.

CVSS V3 rated as High - 7.4 severity.

CVSS V2 rated as Medium - 5.8 severity.

Solution

Please refer to ARUBA-PSA-2021-008 for more information about patching these vulnerabilities.

Vendor References

ARUBA-PSA-2021-008 - www.arubanetworks.com/assets/alert/ARUBA-PSA-2021-008.txt

CVEs related to QID 43856

CVE-2020-25705 |

Software Advisories

Advisory ID	Software	Component	Link
ARUBA-PSA-2021-008			www.arubanetworks.com/assets/alert/ARUBA-PSA-2021-008.txt

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].